Supplementary Figure S10 from LNS8801 inhibits Acute Myeloid Leukemia by inducing the production of reactive oxygen species and activating the endoplasmic reticulum stress pathway
Inyoung Lee(University of Pennsylvania), Todd W. Ridky(University of Pennsylvania), J. Kevin Foskett(University of Pennsylvania), Martin Carroll(University of Pennsylvania), Miriam Doepner(GlaxoSmithKline (United States)), Jillian Weissenrieder(University of Pennsylvania), Sophia Mercado(University of Pennsylvania), Angela Estell(University of Pennsylvania), Christopher A. Natale(University of Pennsylvania), Ariana D. Majer(Bucknell University), Pamela J. Sung(Roswell Park Comprehensive Cancer Center)
Cited by 0
Related Papers
Crenolanib is a selective type I pan-FLT3 inhibitor
|Proceedings of the National Academy of Sciences|2014|211
Suppression of InsP<sub>3</sub>Receptor-Mediated Ca<sup>2+</sup>Signaling Alleviates Mutant Presenilin-Linked Familial Alzheimer's Disease Pathogenesis
|Journal of Neuroscience|2014|109
LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors
|Cell Reports|2019|70
<i>DNMT3A</i> Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia
|Clinical Cancer Research|2015|55
Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome
|Investigational New Drugs|2013|51